Open-access Fatores de risco para hemorragia pós-parto e suas formas graves com perda sanguínea avaliada objetivamente - Um estudo de coorte prospectivo

rbgo Revista Brasileira de Ginecologia e Obstetrícia Rev. Bras. Ginecol. Obstet. 0100-7203 1806-9339 Federação Brasileira das Sociedades de Ginecologia e Obstetrícia Resumo Objetivo Identificar os fatores de risco para hemorragia pós-parto e hemorragia pósparto grave com o sangramento pós-parto avaliado objetivamente. Métodos Trata-se de uma análise complementar de umestudo de coorte prospectivo que incluiu somente mulheres que evoluíram para parto vaginal. O total de perda sanguínea foi avaliado objetivamente durante 24 horas pós-parto através da soma da quantidade de sangue mensurada através de um coletor de sangue pós-parto somado ao peso de compressas, gases e absorventes utilizados no período pós-parto. Análises exploratórias dos dados foram realizadas através do cálculo de médias, desvio-padrão (DP), frequência, porcentagem e percentis. Os fatores de risco foram avaliados através de regressão linear e logística. Resultados Foram incluídas 270 mulheres. A média de perda sanguínea pós-parto após 120 minutos foi de 427.49 mL (±335.57 mL). Trinta e umpor cento (84 mulheres) sangraram> 500mL e 8,2% (22 mulheres) sangraram > 1.000mL em 2 horas. Episiotomia, segundo período do parto prolongado e uso de fórceps estiveram associados a perda sanguínea > 500mL em 2 horas. Na análise multivariada, somente fórceps manteve-se entre os fatores de risco para sangramentos superiores a 500mL em 2 horas (odds ratio [OR] = 9.5 [2.85-31.53]). Anemia prévia e episiotomia estiveram associadas com perda sanguínea > 1.000 mL. Conclusão Segundo período do parto prolongado, fórceps e episiotomia estão associados a aumento da incidência de hemorragia pós-parto e devem ser usados como um alerta para os profissionais de saúde para o reconhecimento precoce e tratamento imediato da patologia. Introduction In spite of the efforts to decrease maternal mortality worldwide, every day 800 women die due to complications related to pregnancy and childbirth.1 Behind the numbers, these premature deaths lead to an impact on families, societies and economies and basically, for the children, mean the loss of a caregiver and nurturing figure.2 At least for the past 25 years, maternal hemorrhage remains the leading cause of maternal mortality worldwide and the majority of deaths occur at the postpartum period in low sociodemographic index countries.34 Postpartum hemorrhage (PPH) is defined by the World Health Organization (WHO) as bleeding > 500 mL within 24 hours after delivery and severe PPH as bleeding > 1,000 mL during the same period.5 For the last years, PPH and severe PPH is increasing around the world, even in developed countries.67 To recognize women at risk who could potentially develop PPH is the first action to prompt treatment to avoid deaths and near-misses due to PPH. Nevertheless, several studies have shown conflicting risk factors for PPH based on visual estimation of blood loss.678910 While some studies identified age < 20 years old, hypertension and multiple gestations68 as a risk factor for PPH, others did not find the relationship among these potential risk factors and postpartum bleeding.7911 The fact is that the majority of the studies evaluate PPH using a visual estimative of blood loss, a low accuracy method to measure postpartum bleeding.121314 The present study aimed to identify risk factors related to PPH and severe PPH with blood loss quantified objectively. Methods This is a complementary analysis of a prospective cohort study designed to identify if shock index and other vital signs could be useful to predict PPH (not published). It included pregnant women with gestational age > 34 weeks delivering vaginally at the Women's Hospital (Hospital da Mulher J.A Pinotti, Campinas, São Paulo, Brazil) between 1 February 2015 and 31 March 2016. The exclusion criteria were the presence of one or more of these conditions: gestational age < 34 weeks, hypertension, hypo or hyperthyroidism without treatment, coagulopathy, antepartum hemorrhage, any cardiac disease and infections with fever or sepsis. During the labor, at the obstetric ward, women were invited to participate in the study, and if accepted, they signed an informed consent form. A data collection form was filled with information from the women's interview added with information from the medical records. The hemoglobin level was checked in prenatal records. If the last dosage had been made before 3 months, we collected a new blood count before delivery. Previous anemia was defined as hemoglobin levels < 11 g/dL. If the women progressed to C-section they were excluded from the study. Immediately after the fetal delivery, trained research assistants placed a calibrated drape under the women's buttocks (BRASSS_V drape_Maternova_Providence, RI, USA – Fig. 1). The total blood loss was obtained through the sum of the volume collected from the drape with the weight of gauzes, compresses and pads (subtracting the dry weight) used by women within 2 hours. For volume estimation, we considered the density of blood to be 1 g/mL.15 Fig. 1 Calibrated drape used to measure objectively blood loss after fetal delivery (BRASSS_V drape_Maternova_Providence, RI, USA). For the statistical analyses, we identified the possible risk factors that could be related to PPH and severe PPH. Therefore, we performed exploratory data analysis to assess mean, standard deviation (SD), minimum, median, maximum, frequency, percentage and percentiles. The risk factors for postpartum bleeding were evaluated using linear and logistic regression. All statistical analysis was made using SAS 9.4 (SAS Institute Inc., SAS São Paulo, São Paulo, Brazil) and we defined a significance level of 5%. The Institutional Review Board (IRB of the Universidade de Campinas, Campinas, SP, Brazil) approved the main study, which included evaluating the risk factors for PPH (CAEE: 26787114.3.0000.5404). Without any participation in planning, designing, implementing, collecting data, analysis and interpreting results, Centro de Pesquisas em Saúde Reprodutiva de Campinas (CEMICAMP) and Fund for Support to Teaching, Research and Outreach Activities (Faepex-UNICAMP) supported the study. Results From the 319 eligible women, 8 denied participation and 41 progressed to C-section. Therefore, we included 270 women. The mean blood loss at 120 minutes was 427.49 mL (±335.57 mL). Thirty-one percent (84 women) of the sample bled > 500 mL and 8.2% (22 women) bled > 1,000mL within 2 hours. On the other hand, among those who bled less, 93 women (34.4%) had blood loss ≤ 300 mL and 125 (46.3%) had blood loss ≤ 400mL, below the mean blood loss. Forty-seven women (17.4%) arrived at the hospital during the second stage of labor. Sociodemographic and obstetrics characteristics are shown in Table 1. Table 1 Sociodemographic and Obstetrics characteristics Characteristics n Mean ± SD Age (years old) 270 24.67 ± 6.2 BMI (antepartum) a 244 28.85 ± 4.6 Parity 270 0.80 ± 1.10 Gestational age (in weeks) 270 38.93 ± 1.47 Education (in years) b 231 9.91 ± 2.5 Time to second stage (in minutes) c 223 32.47 ± 34.7 Initial Hb (in g/dL) d 260 11.45 ± 0.1 Ethnicity - white e 178 (67%) Previous C-Section 42 (15.5%) Spontaneous onset of labor 203 (75.2%) Anesthesia/analgesia (yes) 170 (63%) Mode of delivery  vaginal 247 (91.5%)  forceps 23 (8.5%) Episiotomy (yes) 96 (36%) Laceration (≥ grade 2) 155 (57.1%) Blood loss within 120 minutes  ≥ 500 mL 84 (31%)  ≥ 1000 mL 22 (8.2%) Abbreviations: BMI, body mass index; Hb, hemoglobin. Missing: a 26; b 39; c 47; d 10; e 7; ain Kg/m2. No women in our sample had intensive care unit (ICU) admission or surgical procedures. Only four women received blood transfusions due to PPH. Among those who bled > 500 mL, 18 women (21.4%) had forceps delivery and 38 (45.2%) had an episiotomy. And among those who bled > 1,000 mL, 4 women (18.2%) had forceps delivery, 11 (50%) had an episiotomy and 6 (27.3%) had previous anemia. The logistic regression to evaluate factors related to blood loss after delivery is shown in Table 2. Table 2 Univariate and multivariate analysis of risk factors to blood loss ≥ 500mL and ≥ 1000mL in 2 hours 500 mL within 2 hours 1,000 mL within 2 hours n OR p-value OR p-value (95%CI) (95%CI) Univariate analysis Age  ≤ 19 years old 63 1.51 0.172 1.60 0.329 (0.83 - 2.71) (0.62 - 4.11)  20–35 years old 191 Ref.  ≥ 35 years old 16 1.00 0.990 1.67 0.516 (0.34 - 2.99) (0.35 - 7.87) Ethnicity  white 178 Ref.  non-white 85 0.83 0.534 2.24 0.085 (0.47 - 1.47) (0.89 - 5.61) Schooling (mean in years) 231 1.04 0.431 0.97 0.813 (0.93 - 1.17) (0.80 - 1.18) Overweight (BMIa ≥25) 104 1.36 0.272 0.94 0.900 (0.78 - 2.36) (0.34 - 2.55) Obesity (BMIa ≥ 30) 89 1.03 0.913 1.60 0.350 (0.58 - 1.82) (0.59 - 4.31) Multiparity (two or more previous deliveries) 53 0.65 0.227 0.87 0.817 (0.32 - 1.30) (0.28 - 2.70) Gestational age  34–40 weeks 146 0.92 0.764 1.64 0.277 (0.53 - 1.59) (0.67 - 4.03)  40 weeks 102 Ref. Previous C-section 42 1.13 0.731 1.65 0.351 (0.56 - 2.28) (0.57 - 4.75) Anemia (hemoglobin ≤ 11 g/dl) 43 1.60 0.175 2.82 0.037 (0.81 - 3.15) (1.06 - 7.47) Spontaneous labor 203 0.58 0.062 0.87 0.780 (0.32 - 1.03) (0.32 - 2.32) Duration of second-stage of labor ≥ 30 minutes 223 1.88 0.032 1.90 0.230 (1.05–3.37) (0.66–5.45) Anesthesia (yes) 168 1.225 0.458 1.068 0.886 (0.71–2.09) (0.43–2.64) Episiotomy (yes) 96 2.39 0.001 3.05 0.017 (1.39 - 4.10) (1.12 - 7.66) Laceration (≥ grade 2) 144 1.03 0.924 1.64 0.300 (0.60 - 1.74) (0.64 - 4.22) Forceps (yes) 23 9.87 <0.001 2.68 0.101 (3.53 - 27.65) (0.82 - 8.72) Multivariate analysis Forceps (yes) 260 9.48 <0.001 (2.85 - 31.53) Duration of second stage of labor ≥ 30 minutes 260 1.05 0.883 (0.57–2.10) Episiotomy (yes) 260 1.49 0.25 (0.75–2.96) Abbreviations: BMI, body mass index; CI, confidence interval; OR, odds ratio. Episiotomy, longer second stage of labor and forceps delivery were related to blood loss > 500mL within 2 hours. The multiple analysis (n = 260) shows that forceps delivery had an odds ratio (OR) of 9.48 (95% confidence interval [CI]: 2.85–31.53) for bleeding > 500 mL within 2 hours. Previous anemia, longer second stage of labor and episiotomy were also related to blood loss > 1,000 mL. Nevertheless, the multiple analyses had not shown a risk factor related to bleeding > 1,000mL within 2 hours after delivery. Discussion Our study aimed to evaluate risk factors for PPH and severe PPH within 2 hours after delivery with blood loss quantified objectively. Episiotomy, forceps and longer second stage of delivery were related to PPH, and episiotomy and previous anemia were related with severe PPH. The actual research related to PPH is concerned with the early identification of PPH in an attempt to promote, with the prompt and accurate treatment, the decrease of maternal mortality and near-miss due to PPH. The identification of risk factors could contribute as an adjunct for early recognition of PPH.101617 The main contributors to developing PPH and severe PPH in our study were forceps, longer second stage of labor and episiotomy, which are frequently described in the literature; nevertheless, in our study, maternal age > 35 years, multiparity, induced labor and previous C-sections were not related to PPH and severe PPH, as they were found as risk factors for PPH in other several studies.678918 Forceps delivery had an OR of 9.48 for the risk of developing PPH, although our analysis does not show forceps as a risk factor for severe PPH as demonstrated in other studies.89 Perhaps, this difference could be explained by the quantifying method to measured postpartum bleeding or by the number of women with severe PPH in our study, as only 22 women had severe PPH, while other studies, which were population studies, found > 3,000 women with severe PPH.89 Previous anemia (hemoglobin level < 11 g/dl) was found to be a risk factor for severe PPH. This is in agreement with another study that found hemoglobin levels < 9 g/dl as a risk factor for severe PPH, OR = 2.20 (1.63–3.15).9 Our data shows the importance of adequate antenatal care with diagnosis and treatment of anemia as a changeable risk factor for PPH. Iron supplementation is a recommendation of the WHO during pregnancy and the postpartum period1920 and could decrease a part of the incidence of PPH. Also, the presence of previous anemia may influence the recovery after bleeding. Comparing the objective method of measuring PPH, one study from Uganda assessed postpartum bleeding using a calibrated drape. The risk factors found by them were HIV positive, multiple pregnancy and macrosomia.11 Nevertheless, they had a very low frequency of PPH (9%) and severe PPH (1.2%)11 compared with our data, which shows respectively 31% and 8.2% of frequency. In our sample, only 11 women delivered babies > 4,000 g and 8 of them had postpartum bleeding > 500mL. Our data showed that prolonged second-stage labor, forceps and episiotomy, which are very linked to each other, are related to an increased incidence of PPH. In the modern assistance to labor and delivery, it is recommended to respect the obstetrical physiological variations found among women.21 However, if an operative delivery or even episiotomy is required, the team should be prepared for the possibility of facing a PPH, and these three risk factors should be used as an alert for the delivery assistants for early recognition and prompt treatment for PPH. Although our study has the strength of evaluating objectively the postpartum bleeding for 2 hours, a rare characteristic found in studies that evaluate risk factors, it has some limitations. Our sample size is limited, only 270 women were included, and we excluded pregnant women with hypertension, a known risk factor for PPH. Ideally, we should have divided the comparison of the second stage of labor between above and below 1 hour. However, our sample size was not sufficient for this. Future research with PPH should be done evaluating postpartum bleeding objectively in a large sample size and with no exclusion criteria. Conclusion Prolonged second stage of labor, forceps and episiotomy are related to PPH, and should be used as an alert for the delivery assistants for early recognition and prompt treatment for PPH. Acknowledgments We thank the statistical group from the Faculdade de Medicina of the Universidade de Campinas, Campinas, SP, Brazil for data analysis. CEMICAMP and Faepex - Unicamp funded the present research. References 1 1 Kendall T, Langer A. Critical maternal health knowledge gaps in low- and middle-income countries for the post-2015 era. Reprod Health. 2015;12:55. Doi: 10.1186/s12978-015-0044-5 Kendall T Langer A Critical maternal health knowledge gaps in low- and middle-income countries for the post-2015 era Reprod Health 2015 12 55 55 10.1186/s12978-015-0044-5 2 2 Knaul FM, Langer A, Atun R, Rodin D, Frenk J, Bonita R. Rethinking maternal health. Lancet Glob Health. 2016;4(04):e227-e228. Doi: 10.1016/S2214-109X(16)00044-9 Knaul FM Langer A Atun R Rodin D Frenk J Bonita R Rethinking maternal health Lancet Glob Health 2016 4 04 e227 e228 10.1016/S2214-109X(16)00044-9 3 3 GBD 2015 Maternal Mortality Collaborators. Global, regional, and national levels ofmaternalmortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388 (10053):1775-1812. Doi: 10.1016/S0140-6736(16)31470-2 GBD 2015 Maternal Mortality Collaborators 1990 Global regional, and national levels ofmaternalmortality 10.1016/S0140-6736(16)31470-2 4 4 Say L, Chou D, Gemmill A, Tunçalp Ö, Moller A-B, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(06):e323-e333. Doi: 10.1016/S2214- 109X(14)70227-X Say L Chou D Gemmill A Tunçalp Ö Moller A-B Daniels J Global causes of maternal death a WHO systematic analysis Lancet Glob Health 2014 2 06 e323 e333 5 5 Tunçalp O, Souza JP, Gülmezoglu MWorld Health Organization. New WHO recommendations on prevention and treatment of postpartum hemorrhage. Int J Gynaecol Obstet. 2013;123(03): 254-256. Doi: 10.1016/j.ijgo.2013.06.024 Tunçalp O Souza JP Gülmezoglu MWorld Health Organization New WHO recommendations on prevention and treatment of postpartum hemorrhage Int J Gynaecol Obstet 2013 123 03 254 256 10.1016/j.ijgo.2013.06.024 6 6 Bateman BT, BermanMF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg. 2010;110(05):1368-1373. Doi: 10.1213/ ANE.0b013e3181d74898 Bateman BT Berman MF Riley LE Leffert LR The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries Anesth Analg 2010 110 05 1368 1373 7 7 Goffman D, Nathan L, Chazotte C. Obstetric hemorrhage: A global review. Semin Perinatol. 2016;40(02):96-98. Doi: 10.1053/j.semperi. 2015.11.014 Goffman D Nathan L Chazotte C Obstetric hemorrhage A global review Semin Perinatol 2016 40 02 96 98 10.1053/j.semperi 8 8 Kramer MS, Berg C, Abenhaim H, DahhouM, Rouleau J,Mehrabadi A, Joseph KS. Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. Am J Obstet Gynecol. 2013;209(05): 449.e1-449.e7. Doi: 10.1016/j.ajog.2013.07.007 Kramer MS Berg C Abenhaim H Dahhou M Rouleau J Mehrabadi A Joseph KS Incidence, risk factors, and temporal trends in severe postpartum hemorrhage Am J Obstet Gynecol 2013 209 05 449 449 10.1016/j.ajog.2013.07.007 9 9 Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B. Prevalence and risk factors of severe obstetric haemorrhage. BJOG. 2008;115(10): 1265-1272. Doi: 10.1111/j.1471-0528.2008.01859.x Al-Zirqi I Vangen S Forsen L Stray-Pedersen B Prevalence and risk factors of severe obstetric haemorrhage BJOG 2008 115 10 1265 1272 10.1111/j.1471-0528.2008.01859.x 10 10 Pacagnella RC, Borovac-Pinheiro A. Assessing and managing hypovolemic shock in puerperal women. Best Pract Res Clin Obstet Gynaecol. 2019;61:89-105. Doi: 10.1016/j.bpobgyn.2019.05.012 Pacagnella RC Borovac-Pinheiro A Assessing and managing hypovolemic shock in puerperal women Best Pract Res Clin Obstet Gynaecol 2019 61 89 105 10.1016/j.bpobgyn.2019.05.012 11 11 Ononge S,Mirembe F,Wandabwa J, Campbell OMR. Incidence and risk factors for postpartum hemorrhage in Uganda. Reprod Health. 2016;13:38. Doi: 10.1186/s12978-016-0154-8 Ononge S Mirembe F Wandabwa J Campbell OMR Incidence and risk factors for postpartum hemorrhage in Uganda Reprod Health 2016 13 38 38 10.1186/s12978-016-0154-8 12 12 Patel A, Goudar SS, Geller SE, Kodkany BS, Edlavitch SA, Patted SS, et al. Drape estimation vs. visual assessment for estimating postpartum hemorrhage. Int J Gynaecol Obstet. 2006;93(03): 220-224. Doi: 10.1016/j.ijgo.2006.02.014 Patel A Goudar SS Geller SE Kodkany BS Edlavitch SA Patted SS Drape estimation vs visual assessment for estimating postpartum hemorrhage Int J Gynaecol Obstet 2006 93 03 220 224 10.1016/j.ijgo.2006.02.014 13 13 Toledo P, McCarthy RJ, Hewlett BJ, Fitzgerald PC, Wong CA. The accuracy of blood loss estimation after simulated vaginal delivery. Anesth Analg. 2007;105(06):1736-1740. Doi: 10.1213/01.ane.0000 286233.48111.d8 Toledo P McCarthy RJ Hewlett BJ Fitzgerald PC Wong CA The accuracy of blood loss estimation after simulated vaginal delivery Anesth Analg 2007 105 06 1736 1740 10.1213/01.ane.0000 14 14 Schorn MN. Measurement of blood loss: review of the literature. J MidwiferyWomens Health. 2010;55(01):20-27. Doi: 10.1016/j. jmwh.2009.02.014 Schorn MN Measurement of blood loss review of the literature J MidwiferyWomens Health 2010 55 01 20 27 15 15 MacLeod JH. Estimation of blood loss in a small community hospital. Can Med Assoc J. 1966;95(03):114-117 MacLeod JH Estimation of blood loss in a small community hospital Can Med Assoc J 1966 95 03 114 117 16 16 Borovac-Pinheiro A, Pacagnella RC, Cecatti JG, Miller S, El Ayadi AM, Souza JP, et al. Postpartum hemorrhage: new insights for definition and diagnosis. Am J Obstet Gynecol. 2018;219(02): 162-168. Doi: 10.1016/j.ajog.2018.04.013 Borovac-Pinheiro A Pacagnella RC Cecatti JG Miller S El Ayadi AM Souza JP Postpartum hemorrhage new insights for definition and diagnosis Am J Obstet Gynecol 2018 219 02 162 168 10.1016/j.ajog.2018.04.013 17 17 Borovac-Pinheiro A, Ribeiro FM, Morais SS, Pacagnella RC. Shock index and heart rate standard reference values in the immediate postpartum period: A cohort study. PLoS One. 2019;14(06): e0217907. Doi: 10.1371/journal.pone.0217907 Borovac-Pinheiro A Ribeiro FM Morais SS Pacagnella RC Shock index and heart rate standard reference values in the immediate postpartum period A cohort study PLoS One 2019 14 06 e0217907 10.1371/journal.pone.0217907 18 18 SheldonWR, Blum J, Vogel JP, Souza JP, Gülmezoglu AM,Winikoff BWHO Multicountry Survey on Maternal and Newborn Health Research Network. Postpartum haemorrhage management, risks, and maternal outcomes: findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121(Suppl 1):5-13. Doi: 10.1111/1471-0528.12636 Sheldon WR Blum J Vogel JP Souza JP Gülmezoglu AM Winikoff BWHO Multicountry Survey on Maternal and Newborn Health Research Network Postpartum haemorrhage management, risks, and maternal outcomes findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health BJOG 2014 121 Suppl 1 5 13 10.1111/1471-0528.12636 19 19 World Health Organization. Daily iron and folic acid supplementation during pregnancy. Geneva: WHO; 2016 World Health Organization Daily iron and folic acid supplementation during pregnancy 2016 Geneva WHO 20 20 Peña-Rosas JP, De-Regil LM,Garcia-CasalMN, Dowswell T.Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015;(07):CD004736. Doi: 10.1002/14651858.CD004736.pub5 Peña-Rosas JP De-Regil LM Garcia-Casal MN Dowswell T Daily oral iron supplementation during pregnancy Cochrane Database Syst Rev 2015 07 CD004736 CD004736 10.1002/14651858.CD004736.pub5 21 21 National Institute for Health and Care Excellence. Intrapartumcarefor healthy women and babies: clinical guideline [Internet]. 2017 [cited 2020 Jan 10]. Available from: https://www.nice.org.uk/guidance/ cg190/resources/intrapartum-care-for-healthy-women-and-babiespdf- 35109866447557 National Institute for Health and Care Excellence Intrapartumcarefor healthy women and babies: clinical guideline [Internet] 2017 https://www.nice.org.uk/guidance/ cg190/resources/intrapartum-care-for-healthy-women-and-babiespdf- 35109866447557
location_on
Federação Brasileira das Sociedades de Ginecologia e Obstetrícia Av. Brigadeiro Luís Antônio, 3421, sala 903 - Jardim Paulista, 01401-001 São Paulo SP - Brasil, Tel. (55 11) 5573-4919 - Rio de Janeiro - RJ - Brazil
E-mail: editorial.office@febrasgo.org.br
rss_feed Acompanhe os números deste periódico no seu leitor de RSS
Acessibilidade / Reportar erro